Thursday, May 14, 2015 1:46:03 PM
Unless they botch their dumping, and violate Rule 144, the SEC won't care. The stock involved isn't registered.
Like BKEN they can issue false PRs, and submit their OTC filings never reviewed by the SEC. After all it is said financing microcrap scam stocks representing small business, is the life blood of the US economy. Or the blood of sumpthin.
It will be a repeat of BKEN. A couple of P&Ds, where Hemp is a crowd favorite. Then it's time to move onto the next scam.
The only other place they could screw up is actually marketing some hemp product, that run afoul of some FDA regulation. But the scam artists will probably avoid that by marketing nothing.
The Jewel of the Mind is Colored with the Hue of what it Imagines
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM